Cite
HARVARD Citation
Eikelboom, J. et al. (2022). Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial. European heart journal. 8 (8), pp. 786-795. [Online].